Medical Condition News

RSS

Pairing Avastin with dasatinib can stop lethal spread of glioblastoma multiforme

The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain for reasons no one previously has understood. Now, Mayo Clinic researchers have found out why this happens.

15 Feb 2013

Researchers show how gene mutations shift and evolve over time in chronic lymphocytic leukemia

Tumors are not factories for the mass production of identical cancer cells, but are, in reality, patchworks of cells with different patterns of gene mutations. In a new study, researchers at Dana-Farber Cancer Institute and the Broad Institute show, more fully than ever before, how these mutations shift and evolve over time in chronic lymphocytic leukemia (CLL) - providing a strobe-like look at the genetic past, present, and future of CLL tumors.

15 Feb 2013

Dompé initiates enrollment in rhNGF phase I/II REPARO study for neurotrophic keratitis

The first patient has been enrolled in the phase I/II REPARO study, the first international clinical trial evaluating the ophthalmological use of a topical solution of recombinant human Nerve Growth Factor (rhNGF) for the treatment of moderate to severe neurotrophic keratitis (NK).

15 Feb 2013

Physical activity may reduce risk of depression in patients undergoing bariatric surgery

Adults undergoing bariatric surgery who are more physically active are less likely to have depressive symptoms and to have recently received medication or counseling for depression or anxiety than their less active counterparts, according to new research led by the University of Pittsburgh Graduate School of Public Health.

15 Feb 2013

People with resilient personality profile more likely to have greater energy levels

People with a more resilient personality profile are more likely to have greater energy levels. That's one of the conclusions from a four-year research project led by Antonio Terracciano, associate professor of geriatrics at the Florida State University College of Medicine. His findings are outlined in "Personality, Metabolic Rate and Aerobic Capacity," published in PLOS ONE, a peer-reviewed, open access journal.

15 Feb 2013

FDA committee recommends approval of Guerbet’s Dotarem NDA for adults and children

Guerbet, the contrast agent specialist for medical imaging, today announced that the Medical Imaging Drugs Advisory Committee to US Food and Drug Administration (FDA) has voted unanimously by votes of 17 to 0 to recommend that FDA approve the New Drug Application (NDA) for Dotarem (gadoterate meglumine) for adults, and for pediatric use for children two years of age and older.

15 Feb 2013

Marshfield Clinic’s Heart Health Mobile app wins HSS competition

Marshfield Clinic Research Foundation, a division of Marshfield Clinic, announced today that its first completed mobile app has won a national competition that challenged competitors to develop a program that will help improve heart health in the U.S.

15 Feb 2013

SANA releases new video on Benefits of Soyfoods for Active Adults

The Soyfoods Association of North America today announced that it has released a video on the Benefits of Soyfoods for Active Adults demonstrating how soyfoods can help you stay fit and healthy. Americans who are trying to lead healthier lives will find that soyfoods boost their energy, improve heart health, and provide antioxidants.

15 Feb 2013

Aspen Dental to inaugurate new office in Gallatin, TN on Feb. 21

Aspen Dental is proud to announce that a new Aspen Dental office is opening in Gallatin, TN on Thursday, Feb. 21. Located at 1007 Nashville Pike, the practice will provide dental services that range from dentures and preventive care to general dentistry and restoration.

15 Feb 2013

Third Rock Ventures announces formation of Jounce Therapeutics

Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.

15 Feb 2013

Benaroya Research Institute establishes T1D Exchange Biobank Operations Center

In a major effort to advance discoveries in type 1 diabetes research, the Benaroya Research Institute at Virginia Mason (BRI) established the T1D Exchange Biobank Operations Center with a $4.4 million grant from The Leona M. and Harry B. Helmsley Charitable Trust.

15 Feb 2013

Virgin HealthMiles announces partnership with vielife

vielife, the global provider of health and wellness solutions, has today announced a partnership with Virgin HealthMiles. The partnership will enable Virgin HealthMiles to offer its customers' employees online health coaching as a flexible tool to encourage the adoption of healthier lifestyle choices.

15 Feb 2013

University of Granada’s melatonin gel effective against mucositis

Mucositis is one of the most frequent side effects of chemotherapy and radiotherapy in cancer patients and currently cannot be treated. Investigators at the University of Granada have patented a melatonin gel that is 100% effective against this inflammatory reaction.

15 Feb 2013

Aspen Dental to inaugurate new office in Canton, GA

Aspen Dental is proud to announce that a new Aspen Dental office is opening in Canton, GA on Thursday, Feb. 21. Located at 2030 Cumming Hwy., the practice will provide dental services that range from dentures and preventive care to general dentistry and restoration.

15 Feb 2013

ReCor Medical initiates PARADISE system post-market study in high blood pressure

ReCor Medical announced today that it has commenced a 50-patient, post-market study across multiple sites in Europe with its CE-marked next-generation PARADISE system, a minimally invasive 6Fr Over-The-Wire (OTW) ultrasound device for treating resistant high blood pressure.

15 Feb 2013

Castle Biosciences launches MyUvealMelanoma website

Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of MyUvealMelanoma.com, a website created to educate newly diagnosed patients, their families and healthcare providers about the most common form of eye cancer. MyUvealMelanoma tells the story of this disease, its treatment and the importance of prognostic testing, through the experience of patients who recently faced this devastating diagnosis first-hand.

15 Feb 2013

ADAMTS7 enzyme plays a crucial role in coronary heart disease

Scientists investigating how certain genes affect an individual's risk of developing coronary heart disease have identified a new therapeutic target, according to research published today in The American Journal of Human Genetics.

15 Feb 2013

LLS, The Myeloproliferative Neoplasm Research Foundation issue MF Challenge Grant

In 2012, The Myeloproliferative Neoplasm (MPN) Research Foundation and The Leukemia & Lymphoma Society (LLS) jointly issued the MF Challenge Grant , seeking innovative approaches to reversing fibrosis in patients with myelofibrosis (MF).

15 Feb 2013

EMAS publishes clinical guide on lichen sclerosus in Maturitas journal

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of a clinical guide by the European Menopause and Andropause Society (EMAS) in its journal Maturitas on lichen sclerosus with summary recommendations.

15 Feb 2013

Exposure to two common PFCs associated with increased risk of osteoarthritis

A new study has linked exposure to two common perfluorinated chemicals (PFCs) with osteoarthritis. PFCs are used in more than 200 industrial processes and consumer products including certain stain- and water-resistant fabrics, grease-proof paper food containers, personal care products, and other items.

15 Feb 2013

Medical Condition News

Pairing Avastin with dasatinib can stop lethal spread of glioblastoma multiforme

Researchers show how gene mutations shift and evolve over time in chronic lymphocytic leukemia

Dompé initiates enrollment in rhNGF phase I/II REPARO study for neurotrophic keratitis

Physical activity may reduce risk of depression in patients undergoing bariatric surgery

People with resilient personality profile more likely to have greater energy levels

FDA committee recommends approval of Guerbet’s Dotarem NDA for adults and children

Marshfield Clinic’s Heart Health Mobile app wins HSS competition

SANA releases new video on Benefits of Soyfoods for Active Adults

Aspen Dental to inaugurate new office in Gallatin, TN on Feb. 21

Third Rock Ventures announces formation of Jounce Therapeutics

Benaroya Research Institute establishes T1D Exchange Biobank Operations Center

Virgin HealthMiles announces partnership with vielife

University of Granada’s melatonin gel effective against mucositis

Aspen Dental to inaugurate new office in Canton, GA

ReCor Medical initiates PARADISE system post-market study in high blood pressure

Castle Biosciences launches MyUvealMelanoma website

ADAMTS7 enzyme plays a crucial role in coronary heart disease

LLS, The Myeloproliferative Neoplasm Research Foundation issue MF Challenge Grant

EMAS publishes clinical guide on lichen sclerosus in Maturitas journal

Exposure to two common PFCs associated with increased risk of osteoarthritis

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News